100 related articles for article (PubMed ID: 12388663)
1. Pluronic p85 block copolymer enhances opioid peptide analgesia.
Witt KA; Huber JD; Egleton RD; Davis TP
J Pharmacol Exp Ther; 2002 Nov; 303(2):760-7. PubMed ID: 12388663
[TBL] [Abstract][Full Text] [Related]
2. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV
Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127
[TBL] [Abstract][Full Text] [Related]
3. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE).
Witt KA; Huber JD; Egleton RD; Roberts MJ; Bentley MD; Guo L; Wei H; Yamamura HI; Davis TP
J Pharmacol Exp Ther; 2001 Aug; 298(2):848-56. PubMed ID: 11454951
[TBL] [Abstract][Full Text] [Related]
5. Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient mice.
Chen C; Pollack GM
J Pharmacol Exp Ther; 1998 Nov; 287(2):545-52. PubMed ID: 9808679
[TBL] [Abstract][Full Text] [Related]
6. Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect.
Witt KA; Huber JD; Egleton RD; Davis TP
J Pharmacol Exp Ther; 2000 Dec; 295(3):972-8. PubMed ID: 11082431
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
[TBL] [Abstract][Full Text] [Related]
8. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
Greene DL; Hau VS; Abbruscato TJ; Bartosz H; Misicka A; Lipkowski AW; Hom S; Gillespie TJ; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1996 Jun; 277(3):1366-75. PubMed ID: 8667199
[TBL] [Abstract][Full Text] [Related]
9. Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells.
Batrakova EV; Li S; Alakhov VY; Miller DW; Kabanov AV
J Pharmacol Exp Ther; 2003 Feb; 304(2):845-54. PubMed ID: 12538842
[TBL] [Abstract][Full Text] [Related]
10. Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
Abbruscato TJ; Williams SA; Misicka A; Lipkowski AW; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1996 Mar; 276(3):1049-57. PubMed ID: 8786534
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain disposition and antinociceptive effects of -D-penicillamine2,5-enkephalin in the mouse.
Chen C; Pollack GM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1151-9. PubMed ID: 9399988
[TBL] [Abstract][Full Text] [Related]
12. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs.
Weber SJ; Abbruscato TJ; Brownson EA; Lipkowski AW; Polt R; Misicka A; Haaseth RC; Bartosz H; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1993 Sep; 266(3):1649-55. PubMed ID: 8371162
[TBL] [Abstract][Full Text] [Related]
13. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.
Batrakova EV; Li S; Vinogradov SV; Alakhov VY; Miller DW; Kabanov AV
J Pharmacol Exp Ther; 2001 Nov; 299(2):483-93. PubMed ID: 11602658
[TBL] [Abstract][Full Text] [Related]
15. Chronic morphine-induced loss of the facilitative interaction between vasoactive intestinal polypeptide and delta-opioid: involvement of protein kinase C and phospholipase Cbetas.
Liu NJ; Chakrabarti S; Gintzler AR
Brain Res; 2004 Jun; 1010(1-2):1-9. PubMed ID: 15126111
[TBL] [Abstract][Full Text] [Related]
16. Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.
Witt KA; Slate CA; Egleton RD; Huber JD; Yamamura HI; Hruby VJ; Davis TP
J Neurochem; 2000 Jul; 75(1):424-35. PubMed ID: 10854288
[TBL] [Abstract][Full Text] [Related]
17. The influence of dextromethorphan on morphine analgesia in Swiss Webster mice is sex-specific.
Grisel JE; Allen S; Nemmani KV; Fee JR; Carliss R
Pharmacol Biochem Behav; 2005 May; 81(1):131-8. PubMed ID: 15894070
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation.
Chen C; Pollack GM
Pharm Res; 1999 Feb; 16(2):296-301. PubMed ID: 10100317
[TBL] [Abstract][Full Text] [Related]
19. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
